
Reference data for this compound is being added. Every lot still ships with its third-party Certificate of Analysis.
Contents Cathelicidin LL-37 Form / storage Lyophilized powder; store at −20 °C, protect from light Purity ≥98% — see lot COA CAS 154947-66-7 Molecular formula C205H340N60O53 Molecular weight ~4493 g/mol Testing Identity (UV/Vis λmax), purity, assay (Beer-Lambert), heavy metals, microbial (TAMC/TYMC) COA Batch-specific — view on this page Research background LL-37 is a 37-residue cationic peptide released from the C-terminus of the human cathelicidin precursor hCAP18 — the only cathelicidin-family antimicrobial peptide in humans and a long-standing subject of innate-immunity research. Its amphipathic helical structure underlies its studied interaction with microbial membranes. Beyond direct antimicrobial investigation, it is studied for immunomodulatory roles including chemotaxis, wound-associated signaling, and host-defense pathways. Research applications Antimicrobial membrane-interaction studies in vitro Immunomodulatory / chemotactic signaling in innate immunity Reference peptide in wound-microenvironment / host-defense research Quality & documentation Every lot is tested by an independent third-party laboratory before it enters the catalog.
Purity is measured per lot; panel results per the Analytical Formulations summary report for the lot currently shipping.